Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Eldorado Gold
EGO
$10B
| $52.8M | 0.04% |
6,572,769
+580,700
| +10% | +$4.5M |
|
502
National Bank Holdings
NBHC
$1.94B
| $52.8M | 0.04% |
1,498,300
-47,900
| -3% | -$1.69M |
|
|
MGLN
503
DELISTED
Magellan Health Services, Inc.
MGLN
| $52.7M | 0.04% |
673,819
+40,020
| +6% | +$2.81M |
|
504
First Industrial Realty Trust
FR
$8.39B
| $52.6M | 0.04% |
1,266,500
-590,300
| -32% | -$24.3M |
|
505
Hilton Worldwide
HLT
$72.2B
| $52.5M | 0.04% |
473,700
+120,600
| +34% | +$12.1M |
|
506
Cintas
CTAS
$80.4B
| $52.5M | 0.04% |
780,272
-882,800
| -53% | -$58.1M |
|
507
Delta Air Lines
DAL
$60.2B
| $52.4M | 0.04% |
895,200
-846,600
| -49% | -$47.5M |
|
508
Grupo Aeroportuario Centro Norte
OMAB
$5.18B
| $52.3M | 0.04% |
873,000
+72,500
| +9% | +$3.95M |
|
509
Coca-Cola
KO
$376B
| $52.1M | 0.04% |
940,600
-1,923,500
| -67% | -$103M |
|
510
MGIC Investment
MTG
$6.32B
| $51.7M | 0.04% |
3,647,500
-1,853,500
| -34% | -$25.7M |
|
|
AGR
511
DELISTED
Avangrid, Inc.
AGR
| $51.7M | 0.04% |
1,009,855
-92,900
| -8% | -$4.62M |
|
|
ENIA
512
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $51.5M | 0.04% |
4,690,400
+288,100
| +7% | +$2.86M |
|
|
MDCO
513
DELISTED
Medicines Co
MDCO
| $51.4M | 0.04% |
605,132
-419,600
| -41% | -$28M |
|
|
SNR
514
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $51.4M | 0.04% |
6,713,309
+256,739
| +4% | +$1.9M |
|
515
Hamilton Lane
HLNE
$5.92B
| $50.8M | 0.04% |
852,600
-17,700
| -2% | -$1.02M |
|
516
Ciena
CIEN
$62.5B
| $50.5M | 0.04% |
1,182,074
+383,300
| +48% | +$14.6M |
|
517
Chefs' Warehouse
CHEF
$4.53B
| $50.3M | 0.04% |
1,320,700
-35,600
| -3% | -$1.29M |
|
518
RE/MAX Holdings
RMAX
$268M
| $50.3M | 0.04% |
1,306,700
+52,300
| +4% | +$1.88M |
|
519
JB Hunt Transport Services
JBHT
$26.6B
| $50.3M | 0.04% |
430,644
+347,600
| +419% | +$39.9M |
|
520
CNA Financial
CNA
$13.8B
| $50.3M | 0.04% |
1,121,400
+95,200
| +9% | +$4.3M |
|
521
Wolfspeed
WOLF
$1.63B
| $50M | 0.04% |
1,082,532
+9,790
| +0.9% | +$457K |
|
522
Canadian National Railway
CNI
$77.2B
| $49.8M | 0.04% |
550,702
+247,002
| +81% | +$22.2M |
|
523
Booz Allen Hamilton
BAH
$9.48B
| $49.7M | 0.04% |
698,894
+98,900
| +16% | +$7.04M |
|
524
OneMain Financial
OMF
$7.52B
| $49.6M | 0.04% |
1,175,600
-7,097
| -0.6% | -$287K |
|
|
RETA
525
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $49.5M | 0.04% |
+242,100
| New | +$44.2M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.